CCL2 and melanoma: Melanoma responds to this pro-inflammatory response by releasing suppressive mediators including CSF1, TGF-β, and CCL2, which reprogram micro-glial cells to become trophic, anti-inflammatory cells characterized by increased expression of Arg1, IL-10, and PD-L1.